Assessment of a prognostic MRI biomarker in early de novo Parkinson's disease

BACKGROUND: Commonly used neuroimaging biomarkers in Parkinson's disease (PD) are useful for diagnosis but poor at predicting outcomes. We explored whether an atrophy pattern from whole-brain structural MRI, measured in the drug-naïve early stage, could predict PD prognosis. METHODS: 362 de nov...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Neuroimage Clin
Autores principales: Zeighami, Yashar, Fereshtehnejad, Seyed-Mohammad, Dadar, Mahsa, Collins, D. Louis, Postuma, Ronald B., Dagher, Alain
Formato: Artigo
Lenguaje:Inglês
Publicado: Elsevier 2019
Materias:
Regular Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6742805/
https://ncbi.nlm.nih.gov/pubmed/31514113
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nicl.2019.101986
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares